Assignee
KARUS THERAPEUTICS LTD
GB·18 granted patents·5 pending applications·112 citations·filing 2013–2020
Top patents by PatentIndex Score
23 records- 0194US11291669B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentKARUS THERAPEUTICS LTD·Filed 2020·Granted Apr 5, 2022·4 cites·17 claims
- 0292US9981987B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted May 29, 2018·11 cites·14 claims
- 0391US10035785B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Jul 31, 2018·10 cites·17 claims
- 0491US9580442B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2015·Granted Feb 28, 2017·14 cites·5 claims
- 0590US9938290B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Apr 10, 2018·11 cites·3 claims
- 0689US10668077B2Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agentKARUS THERAPEUTICS LTD·Filed 2016·Granted Jun 2, 2020·4 cites·17 claims
- 0789US9663487B2Phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·13 cites·15 claims
- 0888US10513530B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 24, 2019·5 cites·19 claims
- 0988US10501478B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2018·Granted Dec 10, 2019·5 cites·7 claims
- 1085US9340503B2Scriptaid isosteres and their use in therapyKARUS THERAPEUTICS LTD·Filed 2014·Granted May 17, 2016·7 cites·5 claims
- 1184US10407435B2Diheteroaryl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Sep 10, 2019·6 cites·19 claims
- 1282US10377764B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Aug 13, 2019·5 cites·2 claims
- 1381US10442815B2Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2016·Granted Oct 15, 2019·5 cites·20 claims
- 1481US10150763B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 11, 2018·3 cites·16 claims
- 1580US9862685B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2014·Granted Jan 9, 2018·4 cites·12 claims
- 1679US9676765B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2013·Granted Jun 13, 2017·4 cites·8 claims
- 1770US2020354378A1Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1867US10533003B2Polyheteroarl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Jan 14, 2020·1 cites·7 claims
- 1962US10870624B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 2049US2021038607A1Oxadiazolylthiophene derivatives useful as histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2145US2018235974A1Compounds comprising tricyclic heterocyclic compoundsKARUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2244US2020316062A1Combinations comprising histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2342US2018243317A1Compositions comprising a pi3k inhibitor and an hdac inhibitorKARUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KARUS THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →